Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

024 Pharma Inc (OTC Pink - Limited Information:EEIGD)

2.49
Delayed Data
As of Mar 21
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
10.00
-50.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues319.4K160.5K97.1K64.7K
 
 
 
 
 
Cost of Goods Sold83.7K31.8K38.6K29.7K
 
 
 
 
 
Depreciation And Amortization4.7K9.7K2.2K2.2K
 
 
 
 
 
 
Operating ExpensesGross Income231.0K119.0K56.3K32.9K
 
 
 
 
 
General Expenses603.6K423.4K456.9K481.5K
 
 
 
 
 
Total Operating Expenses692.1K465.0K497.6K513.3K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-372.6K-304.5K-400.6K-448.6K
 
 
 
 
 
Extraordinary Credit--2.0K--0.00
 
 
Extraordinary Charge-19.5K-128.5K-424.6K-254.8K
 
 
 
 
 
Interest Expense On Debt113.0K64.1K60.4K150.1K
 
 
 
 
 
Other Expenses4.4K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-500.2K-494.9K-885.5K-853.5K
 
 
 
 
 
Net Income-500.2K-494.9K-885.5K-853.5K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.166.681.1K5.9K
 
 
 
 
 
Shares To Calculate EPS Diluted3.166.681.1K5.9K
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.00-$750.00-$250.00
 
 
 
EPS Diluted-$157,500.00-$75,000.00-$750.00-$250.00